Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

MLA

Jian-Bing Fan, et al. “Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial.” Journal of Clinical Oncology, vol. 33, Mar. 2015, pp. 701–08. EBSCOhost, https://doi.org/10.1200/jco.2014.57.6298.

APA

Jian-Bing Fan, Monica M. Reinholz, Karla V. Ballman, Beiyun Chen, Eric P. Winer, Ann E. McCullough, Amylou C. Dueck, Julie Gralow, Xochiquetzal J. Geiger, Edith A. Perez, S. Keith Anderson, E. Aubrey Thompson, Yan W. Asmann, George W. Sledge, Kathleen S. Tenner, Robert B. Jenkins, Jeanette E. Eckel-Passow, Krishna R. Kalari, & Jin Jen. (2015). Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial. Journal of Clinical Oncology, 33, 701–708. https://doi.org/10.1200/jco.2014.57.6298

Chicago

Jian-Bing Fan, Monica M. Reinholz, Karla V. Ballman, Beiyun Chen, Eric P. Winer, Ann E. McCullough, Amylou C. Dueck, et al. 2015. “Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial.” Journal of Clinical Oncology 33 (March): 701–8. doi:10.1200/jco.2014.57.6298.